Navigation Links
Reportlinker Adds Global Anti-CD20 Monoclonal Antibodies Industry
Date:10/4/2010

0

Rising Number of MAbs Under Clinical Trials II-30

High Costs Impede MAbs Penetration II-30

Opportunities in Technology Development II-31

Advancements & Challenges in Antibody Production Processes II-31

Increasing Demand for Protein A in MAb Manufacturing II-32

6. RECENT DRUG APPROVALS AND REGULATORY STATUS II-33

RITUXAN RECEIVES FDA APPROVAL FOR THE TREATMENT OF Chronic

Lymphocytic Leukemia II-33

GSK Receives Positive Opinion for Arzerra™ from EMEA II-33

LFB Obtains Orphan Drug Status for LFB-R603 in Europe II-34

FDA Grants Accelerated Approval for GSK and Genmab's

Ofatumumab for Chronic Lymphocytic Leukemia II-34

InNexus's DXL625 Receives Positive Opinion from FDA II-34

Spectrum Pharma Obtains FDA Approval for Zevalin's Expanded

Label in NHL Treatment II-35

Bayer Schering Obtains EU Approval for Zevalin in First-Line

Treatment II-35

7. RECENT INDUSTRY ACTIVITY II-36

Pfizer Discontinues Development of TRU-015; Continues to

Develop SBI-087 II-36

Roche and Biogen Discontinue Ocrelizumab Development in

Rheumatoid Arthritis II-36

Roche and Biogen File Patent Suit Against GSK II-37

Ocrelizumab Meets Primary End-Point In Phase III Trial for RA II-37

Rituxan Plus FC Chemotherapy Shows Improved Survival in

Treatment-Naïve CLL Patients II-37

FDA Declines Early Use of Rituxan in RA II-38

LG Life Sciences Announces New Anti-CD20 Antibody Program II-38

Provenance Acquires Global Rights to New Anti-CD20 Antibody

from Merck II-38

Roche Takes Over Genentech II-39

Pfizer Acquires Wyeth II-39

Spectrum Pharma Acquires Lymphoma Drug Zevalin II-39

Biogen Partners with Genentech and Roche for Development of

GA-101 II-39

Roche, GlycArt and Genentech Team Up for Development of GA-101 II-40

InNexus Biotechnology Discov
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Mich. , Sept. 19, 2014  Diplomat, the ... of David Dreyer to the Board of ... independent director and will also serve as chair of ... almost 30 years of accounting, financial, compliance and operating ... Mr. Dreyer has served as chief financial officer, chief ...
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
(Date:9/19/2014)... 2014 Five MinuteClinic walk-in medical clinics are opening inside ... area. Three clinics opened in Memphis and ... will be added in Springfield on September ... is expected to open October 22.  MinuteClinic is the largest and ... United States . The Memphis ...
Breaking Medicine Technology:David Dreyer Appointed to Diplomat Board of Directors 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3
... , , , , , , , , , ... and LAUSANNE, Switzerland , February 4 ... Debiopharm Group (Debiopharm), a Swiss-based global,biopharmaceutical group of companies with ... medical needs, announce the launch by,Ipsen in France ...
... , REDWOOD CITY, Calif. , Feb. ... financial results for the year ended December 31, 2009 , which ... cash flow positive. , Total revenue for the fourth quarter of 2009 ... in the fourth quarter of 2008.  Product revenue from the Onco type ...
Cached Medicine Technology:Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 2Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 3Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 4Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 5Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 6Genomic Health Announces Year-End 2009 Financial Results 2Genomic Health Announces Year-End 2009 Financial Results 3Genomic Health Announces Year-End 2009 Financial Results 4Genomic Health Announces Year-End 2009 Financial Results 5Genomic Health Announces Year-End 2009 Financial Results 6Genomic Health Announces Year-End 2009 Financial Results 7Genomic Health Announces Year-End 2009 Financial Results 8Genomic Health Announces Year-End 2009 Financial Results 9Genomic Health Announces Year-End 2009 Financial Results 10Genomic Health Announces Year-End 2009 Financial Results 11Genomic Health Announces Year-End 2009 Financial Results 12
(Date:9/19/2014)... September 19, 2014 Outsourcing services provider Profit ... large US IT conglomerate to provide HR outsourcing services in ... as an exclusive partner and will act as a talent ... will deploy over 120 personnel across 3 locations in India ... statement. , "This is a significant win for us and ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Dr. John ... Therapeutic Periodontal Treatment to their Miami practice. Routinely ... Gallardo and Dr. Lamas are one of the ... ‘total health’ approach for diagnosing and treating periodontal disease. ... the most under-diagnosed and under-treated diseases in the world. ...
(Date:9/19/2014)... Dennis Thompson HealthDay Reporter ... President Barack Obama escalated the fight against antibiotic-resistant bacteria ... national strategy to deal with the threat. ... cabinet-level task force charged with crafting a national action ... ordinary and previously treatable bacteria that have become resistant ...
(Date:9/19/2014)... Chino Hills, CA (PRWEB) September 19, 2014 ... the fastest-selling fitness boot camp in the country. He’s also ... mentoring thousands of clients, coaching celebrity trainers and serving as ... He knows marketing, and he says that becoming an integral ... camp’s success. , “One of the things that Fit Body ...
(Date:9/19/2014)... DC (PRWEB) September 19, 2014 Atlantic ... and the authoritative AIS’s Directory of Health Plans — ... Facts, Trends and Data: 2014-2015. The latest edition of ... are re-shaping the health care industry. , With ... plan issues — from benefit design and management strategies ...
Breaking Medicine News(10 mins):Health News:Profit By RPO Bags huge RPO contract from US-based Implementation Partner 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 3Health News:Obama Calls for National Plan to Fight Antibiotic Resistance 2Health News:New Post from Boot Camp Marketing Expert Bedros Keuilian Explains Importance of Becoming Part of the Community 2Health News:New Post from Boot Camp Marketing Expert Bedros Keuilian Explains Importance of Becoming Part of the Community 3Health News:New Book from Atlantic Information Provides Insights Into Trends in the Health Care Industry 2
... but along with her, her families too have to face the ... breast has taken its toll on Ellen who is finding it ... Her family could seem to do nothing to ease the pain. ... palliative care team at Dartmouth Hitchcock Medical Center. ,A doctor ...
... they get married is a waste of breath, a US ... Sydney. // ,William Smith, the vice president of the ... that a six-year study commissioned by the US Congress found ... spent on pushing sexual abstinence outside marriage had had no ...
... only getting closer for the Bush administration and therefore many ... the one cited by the American Civil Liberties Union; they ... the federally sponsored ‘Abstinence Only Sex Education’ programme. ,The ... document compiled by Dr. John Santelli, a pediatrician at the ...
... A mental fog referred to as ‘chemo brain’ that ... it deserves. // , Patients especially women have ... as short-term memory loss, an inability to concentrate, difficulty ... that they had lost their mental edge. Once brushing ...
... found a breakthrough method of blood test to diagnose Parkinson ... blood much before the symptoms arrive. The test is done ... Institute and Melbourne University specialists. ,They have also ... application as it can screen many types of PD and ...
... interfere with the therapeutic effects of chemotherapy agents, ... use of antioxidants during chemotherapy. In fact, they ... the patient’s ability to tolerate treatment. This conclusion ... the use of antioxidant supplements during treatment. Until ...
Cached Medicine News:Health News:The Pain Relieved With the Help of Palliative Workers 2Health News:Chemo Brain- Nothing Forgettable About It 2Health News:Chemo Brain- Nothing Forgettable About It 3Health News:New Blood Test to Diagnose Parkinson Disease 2Health News:Antioxidants May Aid Chemotherapy Patients 2
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Open 11 mm blades. Dull finish. Most popular size or model....
Open 15 mm blades with lifting wings manipulation of I/A cannulas, knives, instrumentation, etc. Screwlocking mechanism. Dull finish....
Angled for temporal approach. Solid 14 mm blades. Dull finish....
Medicine Products: